Union-Tribune (San Diego, Calif.)
December 14, 2005

BIOLOGICAL CIRCUITS OPEN A WORLD OF POSSIBILITIES AND DANGERS

Controlling organisms with biological circuits, opens up a world of
possibilities and dangers

By Susan Brown

For decades, biologists have modified plants and animals by snipping
genes from one organism and popping them into another in a process
called genetic engineering. Corn will produce its own pesticide - a
toxin harmful to caterpillars - when spiked with a bacterial gene. And
copies of the human gene for insulin have been slipped into bacteria,
transforming them into biological drug factories and reducing the need
to extract the hormone from slaughtered pigs.

Until recently, those useful genes had to be found in nature and
transferred from one organism to another. Now our ability to
manipulate biology to suit our needs has taken a startling new turn.
Scientists are using custom-designed DNA, synthesized from scratch, to
create novel biological "circuits" they hope will do anything they can
program them to do.

Their goal is to plan new biological tasks, such as detecting
pathogens and rendering them harmless, with the kind of precision and
control exercised by designers of electrical circuits. They call
themselves synthetic biologists, and they have set out to engineer
life.

Is this a good idea? The goals sound promising: create tiny packets
that travel through the bloodstream to find and treat diseased cells,
design cells to generate replacement organs or bridge a severed spinal
cord, weave high-tech fabrics of proteins from spider silk.

These possibilities have arisen largely from technical advances over
the past few years that have made chemical synthesis of DNA relatively
inexpensive. Custom-designed DNA is available by mail and can be
ordered through the Internet. Researchers specify the sequence of the
gene they desire and pay as little as a dollar per letter of the
genetic code.

The problem is that the sequences of dangerous things, such as the
virus that caused the 1918 influenza pandemic, are public knowledge.
Some worry that a renegade group of synthetic biologists could unleash
something horrifying.

"In an overall sense, the security situation is grave," said Roger
Brent, president and CEO of Molecular Science Institute in Berkeley.
"One can re-synthesize flu. The people who call themselves synthetic
biologists didn't bring this situation about, but they bear some
measure of the responsibility for keeping us safe."

Brent isn't concerned about the field's pioneers. "They're the
products of long apprenticeships, acculturated to using the technology
only for good and never for evil." But he worries about younger
people. A self-taught teenager can pore deeply through a computer
operating system, he said. At this point, manipulating genes requires
more specialized training, but the future may be different.

"Possibly the best protection is promulgation of ethical standards. If
people act now, they can stop a hacker culture from the start."
Scientists and policy makers have begun discussions, but few existing
regulations apply to this new endeavor.

Leaders in the field convened the intercollegiate Genetically
Engineered Machine, or iGEM, competition at the Massachusetts
Institute of Technology in Cambridge last month. Nine teams fielded by
universities and colleges from San Francisco to Zurich presented
projects in a prize-less contest.

"We could have made this another 'robot wars' scenario and got the
kids all excited about bashing each other's biology," said geneticist
George Church, of Harvard University, who helped organize the meeting.
"But we specifically discouraged that and instead encouraged a more
constructive way of looking at things."

Each team picked a goal, some task for their bacteria to accomplish,
then designed a biological circuit to do the job using plug and play
components call BioBricks. Each component is a piece of DNA that can
do a single simple thing, like make a protein to sense light, relay a
signal or fluoresce. The students strung together BioBricks, much like
assembling a simple electrical circuit from an electronics kit, and
stuck them into cells to see if they would boot up properly. Revisions
are always needed.

The UC Berkeley team exploited a bacterial trick called conjugation.
Bacteria naturally exchange bits of DNA through tunnels they form when
they come into close contact. "One of bacteria's favorite things to do
is to spread resistance to antibiotics," said graduate student
Jonathan Goler, who helped coach Berkeley's team.

Instead, the students used the channels - by sliding a strip of DNA
from cell to cell - to send messages they designed. In this case, the
message was the order to make a protein that glows and also an
"address" for the next cell to send the message to. The practical use
isn't yet clear, but the organizers hailed it as a creative new
approach to controlling a group of cells.

Promising directions

Goler's own work addresses a more pressing need. He is part of a team
led by professor Jay Keasling that is engineering bacteria to produce
a drug to treat malaria. The team is using at least 10 genes from
three organisms to forge new machinery within bacterial cells that
will manufacture artemesinin. The potent protein is naturally found in
the wormwood shrub, but in small amounts. Isolating it from the plant
is inefficient and expensive. But if easily grown bacteria can be made
to do the job, the drug could be produced in volume, dropping its
price and making it more widely available.

Former Keasling lab member Christina Smolke, now at the California
Institute of Technology, is working on "smart therapeutics." Her
research group is designing DNA-based probes to detect a type of viral
infection that transforms a normal cell into a cancerous one. "We're
working on small delivery vehicles that could deliver therapy once
they detect the errant cells," she said.

Ron Weiss and colleagues at Princeton University have programmed
bacteria from the human gut to communicate with each other to produce
colorful designs. They have created a "Goldilocks" circuit that lights
up when the concentration of a target chemical is just right.

In one experiment, they designed cells to glow green when they sensed
a high concentration of a signal chemical and red when the
concentration was low. They placed a different set of cells designed
to secrete the signal chemical in a center of a plate of bacteria
food. When the chemical bled out through the goo, like a wine stain on
a table cloth, the sensor cells responded by forming a bull's-eye
pattern - green ringed by red.

If the sensing bacteria could be programmed to detect a contaminant,
they could be sprayed over a chemical spill to highlight the most
dangerous zones with their color patterns, Weiss said.

Arrays of cells could also form more complex patterns as the basis for
generating tissues, even organs. Current attempts encourage cells to
arrange themselves on artificial scaffolding. "The way we're doing
tissue engineering right now, one could claim, is very unnatural,"
Weiss said. "Clearly cells make scaffolds themselves. If we're able to
program them to do that, we might be able to embed them in the site of
injury and have them figure out for themselves what the pattern should
be."

Hello world

An early success in the field, reported in 2000, was a three-gene
program that made bacteria blink on and off like fireflies. That
system mimicked biological clocks that cycle on and off. Most
biological rhythms, though, are regularly reset by cues from the
outside world, such as daylight. Jeff Hasty's lab at UCSD is designing
rhythmic circuits in yeast and mold that synchronize with light
cycles.

"I'm trying to design a minimal circuit needed to maintain these
cycles," said graduate student Natalie Ostroff, who works with yeast.

Light is a favorite signal for synthetic biologists, perhaps because
nature has provided so many examples. For now, most teams have created
cells that signal with colored fluorescent proteins found in
jellyfish.

A team from UC San Francisco and the University of Texas in Austin
hopes to use light detectors tuned to various wave lengths to turn on
specific synthetic circuits. For a start, they borrowed a protein from
blue-green algae that is activated by red light, linked it to an
enzyme that deposits a black pigment and inserted this simple circuit
into bacterial cells. When the cells are spread in a thin sheet and
exposed to light, they act much like a photographic film.

For their inaugural outing at a meeting last year, the team shined
light on their film to form the words "Hello World." Subsequent
efforts produced an image of one of their advisers and the name of the
journal that published their work.

But these are just demonstrations. At UC San Francisco, Christopher
Voight imagines something more useful - creating materials composed of
multiple proteins, like those that make up spider silk, each
contributing properties of strength and elasticity, each controlled by
a color of light.

Keeping it safe

Much of this work is preliminary: jellyfish lights and cells that make
pictures. Getting them to work remains quite a challenge, even for the
brightest minds, so the threat of using the process for intentional
harm is unlikely for the moment. Everyone interviewed for this article
agreed the risk of accident or inadvertent introduction of something
harmful was minuscule.

"You have to remember all these experiments are done in a petri dish,"
Weiss said. "Once you go outside the petri dish, the environment
becomes so complex, the engineered cells have a hard time surviving.
It's easy to imagine dangerous, but to realize it is much more
difficult."

Still, scientists, ethicists and government advisers are meeting now
to decide how best to manage and control this new power. They are
discussing means of monitoring the genes ordered, codes of conduct and
the possibility of licensing scientists.

One emerging practice is the notion of stamping the work with an
identifying mark. "When we synthesize genes, we add a bar code or
signature into the DNA that identifies it as something we made. That
makes it easy to detect," said Drew Endy, of the Massachusetts
Institute of Technology.

The National Science Advisory Board for Biosecurity is currently
considering a code of conduct. Less clear is what the consequences of
violating the code should be and how a code would stop people who
intend to do harm.

Current laws require a permit to work with certain dangerous pathogens
such as anthrax. But those pathogens are listed by species, not by
specific sequences of DNA. "We would like to see regulations expressed
in terms of sequences," said John Mulligan, president and CEO of Blue
Heron Biotechnology. He said his company does screen orders and has
yet to receive one for a suspicious sequence.

But what should happen if Blue Heron or another company does? "Let's
say you're starting up a new company and you're screening and you find
something that looks really horrible," Endy said. "Who do you talk
to?"

Even the controls are preliminary. Weiss advocates constructing
synthetic "self destruct" circuits. "You can actually engineer them to
kill themselves after some amount of time. When it counts to 10, the
cell dies."

That requires cells to count, which happens to have been one of the
projects in the iGEM competition this year.

"We began by talking about counting to infinity," said Robin Kunzler,
a member of the team from Zurich. But that proved too high a hurdle.
Instead they designed a cell that could count to two.

Susan Brown is a Quest intern.